SAB Biotherapeutics (SABS) Short Interest Ratio & Short Volume $2.49 -0.12 (-4.60%) Closing price 07/23/2025 04:00 PM EasternExtended Trading$2.45 -0.04 (-1.65%) As of 08:13 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SAB Biotherapeutics Short Interest DataSAB Biotherapeutics (SABS) has a short interest of 21,300 shares, representing 0.28% of the float (the number of shares available for trading by the public). This marks a -36.98% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 402,443 shares to cover all short positions.Current Short Interest21,300 sharesPrevious Short Interest33,800 sharesChange Vs. Previous Month-36.98%Dollar Volume Sold Short$37.38 thousandShort Interest Ratio0.5 Days to CoverLast Record DateJune 30, 2025Outstanding Shares9,290,000 sharesFloat Size7,490,000 sharesShort Percent of Float0.28%Today's Trading Volume608,599 sharesAverage Trading Volume402,443 sharesToday's Volume Vs. Average151% Short Selling SAB Biotherapeutics? Sign up to receive the latest short interest report for SAB Biotherapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSABS Short Interest Over TimeSABS Days to Cover Over TimeSABS Percentage of Float Shorted Over Time SAB Biotherapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/202521,300 shares $37.38 thousand -37.0%0.3%0.5 $1.76 6/15/202533,800 shares $57.80 thousand -8.2%0.5%0.8 $1.71 5/31/202536,800 shares $68.82 thousand -48.9%0.5%0.8 $1.87 5/15/202572,000 shares $139.68 thousand -27.9%1.0%1.4 $1.94 4/30/202599,900 shares $169.83 thousand +39.7%1.3%1.8 $1.70 4/15/202571,500 shares $98.24 thousand -22.9%1.0%0.7 $1.37 3/31/202592,700 shares $126.07 thousand -19.4%1.2%0.9 $1.36 3/15/2025115,000 shares $185.15 thousand -8.0%1.6%1 $1.61 2/28/2025125,000 shares $213.75 thousand +84.6%1.7%1 $1.71 2/15/202567,700 shares $134.05 thousand -42.8%0.9%0.5 $1.98 Get the Latest News and Ratings for SABS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for SAB Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/2025118,400 shares $259.30 thousand +121.3%1.6%1 $2.19 1/15/202553,500 shares $186.18 thousand +46.6%0.7%0.7 $3.48 12/31/202436,500 shares $138.34 thousand -35.3%0.5%0.4 $3.79 12/15/202456,400 shares $230.11 thousand -43.0%0.8%0.6 $4.08 11/30/202499,000 shares $289.08 thousand +148.1%1.3%1.1 $2.92 11/15/202439,900 shares $123.69 thousand -32.1%0.5%0.5 $3.10 10/31/202458,800 shares $191.69 thousand -26.3%0.8%0.9 $3.26 10/15/202479,800 shares $193.12 thousand +92.3%1.1%1.6 $2.42 9/30/202441,500 shares $112.05 thousand +37.4%0.6%2.3 $2.70 9/15/202430,200 shares $84.26 thousand -12.7%0.4%1.9 $2.79 8/31/202434,600 shares $101.72 thousand +32.1%0.5%3.7 $2.94 8/15/202426,200 shares $58.95 thousand -8.1%0.4%2.6 $2.25 7/31/202428,500 shares $79.09 thousand +8.0%0.4%1.7 $2.78 7/15/202426,400 shares $76.56 thousand -17.0%0.4%1.6 $2.90 6/30/202431,800 shares $98.58 thousand -7.0%0.4%2 $3.10 6/15/202434,200 shares $107.73 thousand +0.9%0.5%2.1 $3.15 5/31/202433,900 shares $89.50 thousand +50.7%0.5%1.9 $2.64 5/15/202422,500 shares $88.43 thousand No Change0.3%1.2 $3.93 4/30/202422,500 shares $96.53 thousand -12.1%0.3%1.7 $4.29 4/15/202425,600 shares $111.62 thousand -11.4%0.3%1.8 $4.36 3/31/202428,900 shares $131.21 thousand +38.3%0.4%1.7 $4.54 3/15/202420,900 shares $115.37 thousand -15.0%0.3%1.1 $5.52 2/29/202424,600 shares $109.72 thousand -37.1%0.3%1.5 $4.46 2/15/202439,100 shares $217.01 thousand +17.8%0.5%2.9 $5.55 1/31/202433,200 shares $199.20 thousand +90.8%0.4%2.8 $6.00 1/15/202417,400 shares $104.05 thousand -2.8%0.2%1.5 $5.98 12/31/202317,900 shares $12.31 thousand -91.4%N/A2.1 $0.69 12/15/2023207,600 shares $153.29 thousand -11.2%0.3%3 $0.74 11/30/2023233,700 shares $227.16 thousand +1.7%0.7%3.8 $0.97 11/15/2023229,800 shares $209.12 thousand -12.1%0.6%4.4 $0.91Your Bank Account Is No Longer Safe (Ad)What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.Get your free guide now by clicking here >> 10/31/2023261,400 shares $261.37 thousand -2.2%0.7%5.2 $1.00 10/15/2023267,200 shares $187.57 thousand -2.8%0.7%6.4 $0.70 9/30/2023274,900 shares $173.19 thousand -10.3%0.7%7.4 $0.63 9/15/2023306,500 shares $199.23 thousand -17.5%0.8%8.5 $0.65 8/31/2023371,600 shares $267.55 thousand +8.8%1.0%7 $0.72 8/15/2023341,500 shares $269.79 thousand -12.3%0.9%5.9 $0.79 7/31/2023389,300 shares $315.33 thousand -12.4%1.1%4.7 $0.81 7/15/2023444,400 shares $385.47 thousand -4.1%1.3%1.6 $0.87 6/30/2023463,200 shares $384.46 thousand +27.2%1.3%0.3 $0.83 6/15/2023364,300 shares $329.69 thousand -14.9%1.0%0.3 $0.91 5/31/2023428,100 shares $381.01 thousand -35.7%1.2%0.3 $0.89 5/15/2023665,400 shares $585.55 thousand +28.3%1.9%0.5 $0.88 4/30/2023518,600 shares $465.86 thousand +287.6%1.5%0.4 $0.90 4/15/2023133,800 shares $97.07 thousand -3.2%0.4%0.1 $0.73 3/31/2023138,200 shares $60.81 thousand -30.1%0.4%3.4 $0.44 3/15/2023197,800 shares $100.88 thousand +17.5%0.6%4.3 $0.51 2/28/2023168,300 shares $109.40 thousand +14.1%0.5%3.2 $0.65 2/15/2023147,500 shares $97.79 thousand -2.8%0.5%2.7 $0.66 1/31/2023151,700 shares $103.06 thousand +3.1%0.5%2.3 $0.68 1/15/2023147,100 shares $109.43 thousand -14.4%0.5%2.1 $0.74 12/30/2022171,800 shares $101.34 thousand -14.4%0.6%2.5 $0.59 12/15/2022200,700 shares $184.68 thousand -6.1%0.7%2.8 $0.92 11/30/2022213,700 shares $230.80 thousand -11.1%0.8%2.8 $1.08 11/15/2022240,300 shares $254.72 thousand +8.2%0.9%3.1 $1.06 10/31/2022222,200 shares $199.98 thousand -15.3%0.8%3.1 $0.90 10/15/2022262,400 shares $208.63 thousand +7.7%0.9%3.8 $0.80 9/30/2022243,600 shares $170.76 thousand +22.8%0.9%3.6 $0.70 9/15/2022198,300 shares $164.59 thousand -22.1%0.7%3.6 $0.83 8/31/2022254,600 shares $178.25 thousand +6.3%1.0%4.5 $0.70 8/15/2022239,500 shares $287.40 thousand -6.4%0.9%4.9 $1.20 7/31/2022255,900 shares $276.37 thousand -3.4%1.0%5.3 $1.08 7/15/2022265,000 shares $315.35 thousand -8.8%1.0%5.7 $1.19 6/30/2022290,700 shares $421.52 thousand +17.1%1.1%4.5 $1.45 6/15/2022248,300 shares $330.24 thousand -19.8%1.0%1.2 $1.33 5/31/2022309,600 shares $606.82 thousand +19.8%1.2%1.5 $1.96 5/15/2022258,500 shares $514.42 thousand -2.5%1.1%1.1 $1.99 4/30/2022265,100 shares $662.75 thousand +3.7%1.1%1.2 $2.50 4/15/2022255,700 shares $736.42 thousand -12.8%1.0%1.1 $2.88 3/31/2022293,200 shares $1.10 million -6.7%1.2%1.3 $3.76 3/15/2022314,400 shares $572.21 thousand -30.0%1.3%2.9 $1.82 2/28/2022449,000 shares $2.23 million -5.9%1.8%2.7 $4.96 2/15/2022477,000 shares $2.57 million -0.1%1.9%2.3 $5.39 1/31/2022477,400 shares $2.77 million +19.7%1.9%1.9 $5.81 1/15/2022398,700 shares $2.69 million -26.9%1.6%1 $6.75 12/31/2021545,400 shares $4.26 million No Change2.2%0.8 $7.81 SABS Short Interest - Frequently Asked Questions What is SAB Biotherapeutics' current short interest? Short interest is the volume of SAB Biotherapeutics shares that have been sold short but have not yet been covered or closed out. As of June 30th, traders have sold 21,300 shares of SABS short. 0.28% of SAB Biotherapeutics' shares are currently sold short. Learn More on SAB Biotherapeutics' current short interest. What is a good short interest percentage for SAB Biotherapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.28% of SAB Biotherapeutics' floating shares are currently sold short. Is SAB Biotherapeutics' short interest increasing or decreasing? SAB Biotherapeutics saw a decline in short interest during the month of June. As of June 30th, there was short interest totaling 21,300 shares, a decline of 37.0% from the previous total of 33,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is SAB Biotherapeutics' float size? SAB Biotherapeutics currently has issued a total of 9,290,000 shares. Some of SAB Biotherapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. SAB Biotherapeutics currently has a public float of 7,490,000 shares. How does SAB Biotherapeutics' short interest compare to its competitors? 0.28% of SAB Biotherapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to SAB Biotherapeutics: Achieve Life Sciences, Inc. (6.48%), Dominari Holdings Inc. (9.61%), Fortress Biotech, Inc. (15.14%), Curis, Inc. (1.05%), Bolt Biotherapeutics, Inc. (5.44%), Molecular Templates, Inc. (0.09%), Amgen Inc. (2.75%), Gilead Sciences, Inc. (1.69%), Vertex Pharmaceuticals Incorporated (1.50%), Regeneron Pharmaceuticals, Inc. (2.16%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks. What does it mean to sell short SAB Biotherapeutics stock? Short selling SABS is an investing strategy that aims to generate trading profit from SAB Biotherapeutics as its price is falling. SABS shares are trading down $0.12 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against SAB Biotherapeutics? A short squeeze for SAB Biotherapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SABS, which in turn drives the price of the stock up even further. How often is SAB Biotherapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SABS, twice per month. The most recent reporting period available is June, 30 2025. More Short Interest Resources from MarketBeat Related Companies Achieve Life Sciences Short Interest Data Dominari Short Interest Data Fortress Biotech Short Interest Data Curis Short Interest Data Bolt Biotherapeutics Short Interest Data Molecular Templates Short Interest Data Amgen Short Interest Data Gilead Sciences Short Interest Data Vertex Pharmaceuticals Short Interest Data Regeneron Pharmaceuticals Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SABS) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredTrump’s $100 Trillion Land Rush Is OnWhat Is "The US: IPO"? You won't hear this on CNBC... but the government may soon open up hundreds of trill...Stansberry Research | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBREAKING: The House just passed 3 pro-crypto bills!Experts Believe Altcoin Season is Here! With this new legislation in effect, crypto experts across the coun...Crypto 101 Media | SponsoredFREE GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...GoldCo Precious Metals | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SAB Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SAB Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
